Peaches Biotech receives the Innova Health 2023 Award for the most innovative project 15/11/2023 Healthcare Innovative drugs Personalized medicine Advanced therapies It is a recognition of the company, its professionals and the advances achieved in its secretome-based therapies Partners - PEACHES BIOTECH S.L.
European Conference on Clinical Research Prague, Czech Republic Del 19/02/2024 to 20/02/2024 Drug discovery Personalized medicine
Nanodecal Embarks on New Funding Round to Manufacture their Rapid Test for Superbug Detect... 31/10/2023 Healthcare Access to innovation Personalized medicine Antibiotic resistance Financing Nanodecal's funding round aims to raise €600,000 to support the development of a rapid test for detecting respiratory... Partners
VIVEbiotech has received the "Business Innovation" award at the XXXII edition of the Basqu... 24/10/2023 Healthcare Innovative drugs Personalized medicine Advanced therapies VIVEbiotech has received the "Innovacion Empresarial/Business Innovation" award at the XXXII edition of the La Noche de... Partners - VIVEbiotech
VIVEbiotech participates in the European MAGIC project 11/07/2023 Healthcare Personalized medicine Advanced therapies Gene editing International EU projects Financing VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is... Partners - VIVEbiotech
The use of cell secretomes opens a new era of advanced therapies 07/07/2023 Drug discovery Innovative drugs Personalized medicine Advanced therapies The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM) celebrating its 1st... Partners - PEACHES BIOTECH S.L.
ZIP Solutions and YIMA Announce Strategic Co-Marketing Agreement for Gene Therapy 05/06/2023 Healthcare Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies International ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI-enabled biotech... Partners - Biotechnology Assets
Fecundis, a medtech company specialising in fertility, starts up at the Barcelona Science ... 18/04/2023 Healthcare Personalized medicine Advanced therapies Fecundis, a medical technology company in the clinical phase, focused on the development of a disruptive technology to... Partners - Parc Científic de Barcelona
ORYZON reports financial results and corporate update for quarter ended March 31, 2023 11/05/2023 Healthcare Innovative drugs Personalized medicine ORY-4001, a selective HDAC-6 inhibitor, nominated as clinical development candidate for neurological diseases such as... Partners
Peaches Biotech receives 598,000 euros from the CDTI for its PRS project on advanced thera... 17/04/2023 Innovative drugs Personalized medicine Advanced therapies The Center for Technological Development and Innovation (CDTI), of the Ministry of Science and Innovation, has approved... Partners - PEACHES BIOTECH S.L.
